Immunotherapy for MS: clinical aspects and trials.
Ebers
G C
GC
Department of Clinical Neurological Sciences, University Hospital, London, Ontario, Canada.
Sibley
W A
WA
Paty
D W
DW
D004311:Double-Blind Method; D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000628:therapy*
D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a